Abstract: Together with information software industry and steel industry, biomedical industry is also among the pillar industries in the Indian economy and India possesses a world pharmacy reputation in the global drug market. The development of biomedical industry is highly dependent on government biomedical industry policy. The paper analyzes the present biomedical industry condition between China and India, and compares the biomedical industry policies between China and India in four aspects: industry structure policy, industry organization policy, industry layout policy and industry technology policy. We found that Indian biomedical industry’s development is superior to that of China though China has the similar development environment with India. By analyzing the promoting effect of Indian biomedical industry policy on its biomedical industry, and combining the existing development problems in Chinese biomedical industry, this paper included several policy recommendations about the development of Chinese biomedical industry: China shall attach importance to the training of large-scale enterprises, encourage enterprises to participate in international cooperation actively, do the work of information exchange within the industrial cluster and infrastructure services well, take the critical breakthrough principle to support R&D of biomedical industry, improve the application standards of Chinese medicine patents to enhance patent quality.

摘要： 生物医药产业、信息软件产业和钢铁产业一起位列印度经济领域的支柱产业，印度在全球仿制药市场享有“世界药房”声誉，生物医药产业的发展高度依赖政府产业政策的制定。分析中印两国生物医药产业发展现状，从产业结构政策、产业组织政策、产业布局政策和产业技术政策4个方面对比中印的产业政策，发现印度生物医药产业的发展要优于与其国情和产业发展基础相似的中国。通过分析印度生物医药产业政策对该国产业发展的促进效应，以及结合中国生物医药产业发展的现存问题，得出对中国生物医药产业发展的政策建议，建议包括：中国应重视对大型企业的培养，鼓励企业积极参与国际合作，做好产业集群内的信息交流和基础设施服务，采取重点突破的原则对生物医药研发进行支持，提高中国医药专利的申请标准，提升专利质量。